Interactions between antidepressants and P‐glycoprotein at the blood–brain barrier: clinical significance of in vitro and in vivo findings von O'Brien, Fionn E, Dinan, Timothy G, Griffin, Brendan T, Cryan, John F

Volltext

P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents von O'BRIEN, Fionn E, O'CONNOR, Richard M, CLARKE, Gerard, DINAN, Timothy G, GRIFFIN, Brendan T, CRYAN, John F

Volltext

Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood–brain barrier permeability von O'Brien, Fionn E., Clarke, Gerard, Dinan, Timothy G., Cryan, John F., Griffin, Brendan T.

Volltext

The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram von O’Brien, Fionn E., O’Connor, Richard M., Clarke, Gerard, Donovan, Maria D., Dinan, Timothy G., Griffin, Brendan T., Cryan, John F.

Volltext

The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat von Donovan, Maria D., O'Brien, Fionn E., Boylan, Geraldine B., Cryan, John F., Griffin, Brendan T.

Volltext

Drugs, genes and the blues: Pharmacogenetics of the antidepressant response from mouse to man von O'Leary, Olivia F., O'Brien, Fionn E., O'Connor, Richard M., Cryan, John F.

Volltext

Chronic P‐glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depression von O'Brien, Fionn E., Moloney, Gerard M., Scott, Karen A., O'Connor, Richard M., Clarke, Gerard, Dinan, Timothy G., Griffin, Brendan T., Cryan, John F.

Volltext